Alopecia areata: an update on etiopathogenesis, diagnosis, and management
C Zhou, X Li, C Wang, J Zhang - Clinical Reviews in Allergy & …, 2021 - Springer
Alopecia areata (AA) is a common chronic tissue-specific autoimmune disease, resulting in
hair loss, that affects up to 2% of the general population. The exact pathobiology of AA has …
hair loss, that affects up to 2% of the general population. The exact pathobiology of AA has …
An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
Alopecia Areata (AA) is a common autoimmune disease characterized by non-scarring hair
loss ranging from patches on the scalp to complete hair loss involving the entire body …
loss ranging from patches on the scalp to complete hair loss involving the entire body …
Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
B King, X Zhang, WG Harcha, JC Szepietowski… - The Lancet, 2023 - thelancet.com
Background Alopecia areata is characterised by non-scarring loss of scalp, face, or body
hair. We investigated the efficacy and safety of ritlecitinib, an oral, selective dual JAK3/TEC …
hair. We investigated the efficacy and safety of ritlecitinib, an oral, selective dual JAK3/TEC …
Baricitinib for the treatment of alopecia areata
E Freitas, E Guttman-Yassky, T Torres - Drugs, 2023 - Springer
Alopecia areata (AA) is a relapsing, chronic, immune-mediated disease characterized by
nonscarring, inflammatory hair loss that can affect any hair-bearing site. AA clinical …
nonscarring, inflammatory hair loss that can affect any hair-bearing site. AA clinical …
Alopecia areata–Current understanding and management
DA Lintzeri, A Constantinou, K Hillmann… - JDDG: Journal der …, 2022 - Wiley Online Library
Alopecia areata (AA) is a chronic, immune‐mediated disease characterized by acute or
chronic non‐scarring hair loss, with a heterogeneity in clinical manifestations ranging from …
chronic non‐scarring hair loss, with a heterogeneity in clinical manifestations ranging from …
Deciphering the molecular mechanisms of stem cell dynamics in hair follicle regeneration
Hair follicles, which are connected to sebaceous glands in the skin, undergo cyclic periods
of regeneration, degeneration, and rest throughout adult life in mammals. The crucial …
of regeneration, degeneration, and rest throughout adult life in mammals. The crucial …
Alopecia areata: a review of the role of oxidative stress, possible biomarkers, and potential novel therapeutic approaches
Alopecia areata (AA) is a dermatological condition characterized by non-scarring hair loss.
Exact etiopathogenesis of AA is still unknown although it is known that several factors …
Exact etiopathogenesis of AA is still unknown although it is known that several factors …
European recommendations for management of immune checkpoint inhibitors‐derived dermatologic adverse events. The EADV task force 'Dermatology for cancer …
Z Apalla, V Nikolaou, D Fattore… - Journal of the …, 2022 - Wiley Online Library
The introduction of immune checkpoint inhibitors (ICIs) opened a new era in oncologic
therapy. The favourable profile of ICIs in terms of efficacy and safety can be overshadowed …
therapy. The favourable profile of ICIs in terms of efficacy and safety can be overshadowed …
Microneedle‐Mediated Delivery of Immunomodulators Restores Immune Privilege in Hair Follicles and Reverses Immune‐Mediated Alopecia
Disorders in the regulatory arm of the adaptive immune system result in autoimmune‐
mediated diseases. While systemic immunosuppression is the prevailing approach to …
mediated diseases. While systemic immunosuppression is the prevailing approach to …
Alopecia areata: current treatments and new directions
Alopecia areata is an autoimmune hair loss disease that is non-scarring and is
characterized by chronic inflammation at the hair follicle level. Clinically, patients' …
characterized by chronic inflammation at the hair follicle level. Clinically, patients' …